Search hospitals > Colorado > Boulder
Boulder Community Hospital
Claim this profileBoulder, Colorado 80301
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
Conducts research for Leukemia
278 reported clinical trials
2 medical researchers
Summary
Boulder Community Hospital is a medical facility located in Boulder, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Leukemia and other specialties. Boulder Community Hospital is involved with conducting 278 clinical trials across 387 conditions. There are 2 research doctors associated with this hospital, such as Nicholas DiBella and Keren Sturtz.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder5 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
97 reported clinical trials
182 drugs studied
Keren SturtzSCL Health Lutheran Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Carcinoma
4 reported clinical trials
14 drugs studied
Clinical Trials running at Boulder Community Hospital
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Colorectal Cancer
Breast Cancer
Cancer
Multiple Myeloma
Squamous Cell Carcinoma
ALK Gene Rearrangement
Mantle Cell Lymphoma
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Boulder Community Hospital?
Boulder Community Hospital is a medical facility located in Boulder, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Leukemia and other specialties. Boulder Community Hospital is involved with conducting 278 clinical trials across 387 conditions. There are 2 research doctors associated with this hospital, such as Nicholas DiBella and Keren Sturtz.